The largest database of trusted experimental protocols

Cytotox onetm homogeneous membrane integrity assay

Manufactured by Promega
Sourced in United States

The CytoTox-ONETM Homogeneous Membrane Integrity Assay is a quantitative, fluorometric method for detecting the release of lactate dehydrogenase (LDH) from damaged cells. It measures the number of nonviable cells in cell-based assays.

Automatically generated - may contain errors

10 protocols using cytotox onetm homogeneous membrane integrity assay

1

Membrane Integrity and Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CytoTox-ONETM Homogeneous Membrane Integrity Assay (Promega, Madison WI) was used to measure the LDH leakage activity as a measure of membrane integrity and cytotoxicity in the cells. For this assay, 50 µL of spent culture media was removed from each well/plate and transferred to black-walled 96-well assay plates. Triton X (0.1%, 100 µL) was added to the two total lysis control wells on each plate (thereby releasing the maximum amount of LDH into the supernatant) and briefly mixed by pipetting to generate total lysis controls for each plate. The presence of LDH was measured by addition of the resazurin, which is converted to the fluorescent chemical resorufin in a reaction coupled to LDH enzymatic activity. Fluorescent emission was detected using a Safire2 microplate reader (Tecan).
+ Open protocol
+ Expand
2

Cytotoxicity Assessment via LDH Release

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells cytotoxicity was evaluated by measuring the activity of lactate dehydrogenase (LDH) released into the medium according to commonly used protocols in our laboratory [42 ,43 (link)]. Briefly, cells were seeded into 96-well plates (1x10 4 cells/well). After artemether or DMSO treatments, the activity of LDH released into the medium was determined using Cyto Tox-ONETM Homogeneous Membrane Integrity Assay (Promega, USA), according to the instructions of the manufacturer. Fluorescence intensity was measured using an Infinite M200 PRO multimode microplate at excitation at 560 nm and emission at 590 nm wavelengths. The released LDH values were normalized to the percentage of the control group.
+ Open protocol
+ Expand
3

LDH Leakage Quantification Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The leakage of LDH was determined using a CytoTox-ONETM Homogeneous Membrane Integrity assay (Promega Corporation). Briefly, 100 µl reaction buffer was transferred to each well (96-well plate) and the samples were incubated at room temperature for 15 min, then 25 µl stop buffer was added. The plates were shaken for 10 sec and the fluorescence intensity was measured at 560/580 nm. The reported data are given in percentages of the results of the respective control groups.
+ Open protocol
+ Expand
4

THP-1 Monocyte Activation and Zymography

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP-1 human monocyte leukemia cell line (ATCC) was grown in RPMI-1640 medium (Gibco, TermoFisher) supplemented with 10% FBS (Sigma-Aldrich), 5,000 U/ml penicillin, 5,000 μg/ml streptomycin, and 200 mM L-glutamine (all from Gibco) at 37°C and 5% CO2 humidity. The cells were subcultured every second-third day.
MaxiSorp 96-well plates were coated overnight at 4°C with human serum albumin (HSA) or immobilized MFAP4 (both 10 μg/ml). The cells seeded (40.000 cells/well) and differentiated with 5 nM phorbol 12-myristate 13-acetate (PMA; Sigma) for 48 h, equilibrated with complete medium for 24 h, and serum-starved for 48 h. The cells were then stimulated with 20 ng/ml TNF (R&D Systems) for 48 h. Zymography on culture supernatants was performed essentially as described above. Cell proliferation rate was assessed using WST-1 assay (Sigma) according to the manufacturer's instructions. Cell viability was assessed by CytoTox-ONETM Homogeneous Membrane Integrity Assay (Promega) according to the manufacturer's instructions. The zymography results were normalized to the cell proliferation index.
+ Open protocol
+ Expand
5

Storax Oil Attenuates Inflammatory Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Refined storax oil was purchased from Tianjin ZHONGXIN Pharmaceutical Group Limited by Share Ltd Darentang Pharmaceutical Factory and conformed to the standard of China Pharmacopeia (2010 version). Dulbecco’s modified Eagle’s medium/F12 (DMEM/F12), glucose-free DMEM, fetal bovine serum (FBS), HBSS, and 0.25% Trypsin-EDTA were obtained from Gibco (Grand Island, NY, USA). CytoTox-ONETM Homogeneous Membrane Integrity Assay and Cell Counting Kit-8 (CCK-8) were purchased from Promega (Madison, WI, USA) and Dojindo (Kumamoto, Japan), respectively. DCFH-DA and Trizol were obtained from Invitrogen (Eugene, USA). Penicillin and streptomycin were purchased from Beyotime (Shanghai, China). Anti-NF-κB p65, anti-p-IκBα antibody, anti-p-IKK antibody, and anti-β-actin antibody were obtained from Cell Signaling Technology (Danvers, MA, USA). Anti-LaminB1 antibody, anti-iNOS antibody, anti-IL-1β antibody, anti-ICAM-1 antibody, and anti-VCAM-1 antibody were purchased from Abcam Technology (Cambridge, MA, USA). SYBR® Select Master Mix and High Capacity cDNA Reverse Transcription Kits were obtained from Applied Biosystems (Foster City, USA).
+ Open protocol
+ Expand
6

Simulated Ischemia-Reperfusion Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following 48 h in serum-free DMEM, cardiomyocytes plated on 12-well tissue plates were subjected to simulated ischemia, induced by replacement of culture media with sterile-filtered Krebs buffer (118 mM NaCl, 4.8 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, 50 mM EDTA. 11.0 mM glucose, 1.75 mM CaCl2), before incubation for 6 h at 37°C under hypoxia (95% N2-5% CO2, using a hypoxia chamber, QNA International, Melbourne, VIC, Australia), with subsequent 48 h reoxygenation as described previously (Qin et al., 2017b (link)). Agonists were dissolved in DMEM or Krebs buffer, and were present for the full duration of hypoxia (H) and reoxygenation (R). At the end of 48 h reoxygenation, culture supernatant aliquots were collected on ice and stored at -80°C for assessment of cardiomyocyte injury via levels of lactate dehydrogenase (LDH) released (Cyto-Tox-OneTM Homogeneous Membrane Integrity Assay, Promega Inc, Dane County, WI, United States). Levels of cardiac troponin (cTnI) released from cardiomyocytes were also determined using a high-sensitivity rat cTnI ELISA kit (Life Diagnostics Inc, West Chester, PA, United States) as per manufacturer’s instructions.
+ Open protocol
+ Expand
7

Evaluating Membrane Integrity and Redox Status

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell membrane integrity was determined using CytoTox-ONETM Homogeneous Membrane Integrity Assay (Promega Corporation, USA). Prior to, and after preservation of the cell sheets for 7 days, the supernatants and the cell sheets were collected, and LDH release was quantified. The amount of LDH release was calculated considering an LDH level of 100% for the total of the cell sheet and supernatants.
After preservation for 7 days, the intracellular GSH/GSSG ratio of the hOEC sheet was measured using GSH/GSSG-Glo™ Assay (Promega Corporation, USA) according to the manufacturer protocol. The amount of fluorescence was measured with Multilabel Reader ARVO™X4 (Perkin Elmer).
+ Open protocol
+ Expand
8

Quantifying Cytokine and Cytotoxicity Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture supernatants were assayed for IL-1β (BioLegend) and IFN-γ (eBiosciences) using ELISA kits according to the manufacturer’s instructions. Lactate dehydrogenase (LDH) was measured using the CytoTox-ONETM Homogeneous Membrane Integrity Assay (Promega Corporation, G7891, Madison, USA) according to the manufacturer’s instructions. The percentage of LDH release (%) was calculated as (LDHExperimental – LDHMedium)/(LDHTritonX-100-treated – LDHMedium)  × 100.34 (link) Caspase-1 levels were determined using the Caspase-Glo® 1 Inflammasome Assay kit (Promega Corporation, G9951, Madison, USA) according to the manufacturer’s instructions. Briefly, BMDCs were treated with MTX for 48 h with/without TCL, and lipopolysaccharide (LPS) plus nigericin (Nig) was added as a positive control and 50 µL supernatant per sample was incubated with 50 µL Caspase-Glo 1 reagent for 30 min. Luminescence was measured using a luminometer (BioTek).35 (link)
+ Open protocol
+ Expand
9

Measuring Membrane Integrity via LDH

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lactate dehydrogenase (LDH) in supernatant was measured using CytoTox-ONETM Homogeneous Membrane Integrity Assay (Promega) according to the manufacturer’s instructions. LDH release (%) was calculated by using the following formula. LDH release (%) = [(value in sample) − (background)]/[(value in Triton X-100-treated sample) − (background)] × 100.
+ Open protocol
+ Expand
10

Cytotoxicity Evaluation of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytotoxic effect of the test compounds was assessed by a fluorometric lactate dehydrogenase assay (CytoTox-ONE TM Homogeneous Membrane Integrity Assay, Promega) according to the manufacturer's protocol. Caco-2 cells in 96-well plates (Greiner CELLSTAR) were incubated with the test compounds for 24 h, after which lactate dehydrogenase release into the culture medium was determined as described previously (7) . Cytotoxicity of the test compounds was expressed as percentage of the values obtained for the 100 % cell lysis control by Triton® X-100.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!